fbpx

Trademark & Copyrights Insights

Supreme Court: PTAB Institution Decisions Cannot Be Appealed, Even on the Basis of Time-Bar Challenges

In an opinion authored by Justice Ginsburg, the Supreme Court ruled today that Section 314 (d) of the U.S. Patent Act, which bars judicial review of Patent Trial and Appeal Board (PTAB) decisions to institute inter partes review (IPR), should preclude appeals of PTAB institution decisions, even where the appeal is based on Section 315(b)’s …

Supreme Court: PTAB Institution Decisions Cannot Be Appealed, Even on the Basis of Time-Bar Challenges Read More »

Patent Filings Roundup: Medtronic Hit with Seven IPRs, Huawei Fields Multiple District Court Complaints

PTAB (31 new filings) Case Number Action Owner Petitioner Patent IPR2020-00687 Filed Parus Holdings Inc. Apple Inc. 9451084 IPR2020-00686 Filed Parus Holdings Inc. Apple Inc. 7076431 IPR2020-00715 Filed Medtronic, Inc. Axonics Modulation Technologies, Inc. 8036756 IPR2020-00714 Filed Medtronic, Inc. Axonics Modulation Technologies, Inc. 9463324 IPR2020-00681 Filed Targeted Radio LLC [Acacia] Unified Patents, LLC 8948684 IPR2020-00718 …

Patent Filings Roundup: Medtronic Hit with Seven IPRs, Huawei Fields Multiple District Court Complaints Read More »

Sanofi Decision Presents Opportunities to Clear the Patent Thicket for Generic Pharmaceuticals

“The Sanofi decision behooves drug sponsor, generic manufacturers, and drug purchasers alike to examine the Orange Book listings for potentially improperly listed patents.” The U.S. Court of Appeals for the First Circuit has made brand companies think twice about creating patent thickets in the Orange Book by resuscitating an antitrust suit against Sanofi by direct …

Sanofi Decision Presents Opportunities to Clear the Patent Thicket for Generic Pharmaceuticals Read More »

Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them

“When we do come up with a vaccine (or more than one) the government is going to be the buyer…. And, if necessary, the government has the power to seize business assets (including inventions) to allow it to deal with a national emergency first and worry about fair compensation later. So, you’ll spend your time …

Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them Read More »

The IP Bar Weighs in on CAFC Denial of Arthrex Rehearing

Yesterday, the U.S. Court of Appeals for the Federal Circuit denied rehearing en banc in Arthrex v. Smith & Nephew. Five of the 12 Federal Circuit judges wrote separately to explain their reasons for denying, or dissenting from denial on, rehearing. IPWatchdog Founder and CEO Gene Quinn said the order reveals a chaotic and disorganized …

The IP Bar Weighs in on CAFC Denial of Arthrex Rehearing Read More »

Death at a Funeral – or Birth? Why the German Court’s Decision on the UPC May Not be the End

“Even if the Alternative for Germany party, which is said to be critical of the UPC, and the communist party, which voted against subsequent UPC related legislation, were to vote against the approval act, the government should have no difficulty in securing a 2/3 majority.” On Friday, March 20, the German Constitutional Court (“Bundesverfassungsgericht”, “BverfG”) …

Death at a Funeral – or Birth? Why the German Court’s Decision on the UPC May Not be the End Read More »

YouTube
LinkedIn
LinkedIn
Share